SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-22-000097
Filing Date
2022-12-12
Accepted
2022-12-12 16:09:53
Documents
13
Period of Report
2022-12-07
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20221207.htm   iXBRL 8-K 40097
5 GRAPHIC tcda-20221207_g1.jpg GRAPHIC 34563
  Complete submission text file 0001595585-22-000097.txt   265570

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20221207.xsd EX-101.SCH 1912
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20221207_lab.xml EX-101.LAB 25149
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20221207_pre.xml EX-101.PRE 13056
7 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20221207_htm.xml XML 11324
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 221457220
SIC: 2834 Pharmaceutical Preparations